Eczema
About Eczema
Eczema is a recognized chronic inflammatory skin condition with rising visibility driven by increasing prevalence, enhanced patient education, and breakthroughs in therapeutics and skincare solutions.
Trend Decomposition
Trigger: Rising incidence of eczema and heightened public and medical awareness.
Behavior change: Patients increasingly adopt structured skincare routines, seek targeted therapies, and use teledermatology and digital health tools for management.
Enabler: Advances in biologic and targeted therapies, expanded OTC emollients, and digital health access lowering care barriers.
Constraint removed: Greater access to novel treatments and improved education reducing stigma and treatment delays.
PESTLE Analysis
Political: Public health campaigns and payer policies influence access to biologic therapies for eczema.
Economic: Growing cost pressures and insurance coverage dynamics affect affordability of advanced treatments.
Social: Increased attention to quality of life and skin health drives patient advocacy and social normalization of eczema management.
Technological: Advancements in biologics, digital dermatology platforms, and at home monitoring tools enable better disease control.
Legal: Regulatory approvals and pharmacovigilance requirements shape availability of new eczema therapies.
Environmental: Climate and stress related triggers influence disease activity and skincare routines.
Jobs to be done framework
What problem does this trend help solve?
It helps individuals control itch, inflammation, and flare ups to improve daily functioning and quality of life.What workaround existed before?
Reliance on broad emollients, generic topical steroids, and trial and error treatment approaches with limited long term control.What outcome matters most?
Long term disease control with minimal side effects, rapid relief from symptoms, and predictable flare management.Consumer Trend canvas
Basic Need: Effective, accessible skin care and disease control.
Drivers of Change: Better therapies, consumer skincare empowerment, and digital health access.
Emerging Consumer Needs: Personalized treatment plans and convenient at home management options.
New Consumer Expectations: Faster relief, fewer side effects, transparent pricing, and doctor patient collaboration.
Inspirations / Signals: Patient advocacy groups, real world evidence, and celebrity or influencer education on eczema care.
Innovations Emerging: New biologics, topical non steroidal therapies, and digital monitoring tools.
Companies to watch
- Regeneron - Co developer of Dupixent (dupilumab), a leading biologic for moderate to severe eczema.
- Sanofi - Co developer of Dupixent with Regeneron; active in eczema and biologic collaboration.
- LEO Pharma - Specializes in dermatology and eczema focused therapies and skincare products.
- Galderma - Dermatology focused company with skincare brands and eczema care solutions.